410
Views
15
CrossRef citations to date
0
Altmetric
Article

ASSOCIATION OF GENETIC POLYMORPHISMS WITH HEPATOTOXICITY IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOMA

, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, PhD, , MD, PhD, , MSc, , PhD, , PhD, , MD, PhD, , PhD & , PhD show all
Pages 344-354 | Received 21 Jul 2009, Accepted 01 Mar 2010, Published online: 29 Jul 2010

REFERENCES

  • Pui CH, Sandlund JT, Pei D, . Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003;290:2001–2007.
  • Aplenc R, Lange B. Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. Br J Haematol. 2004;125:421–434.
  • Ieiri I, Higuchi S, Sugiyama Y. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Expert Opin Drug Metab Toxicol. 2009;5:703–729.
  • Ekhart C, Rodenhuis S, Smits PH, . An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev. 2009;35:18–31.
  • Kishi S, Cheng C, French D, . Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 2007;109:4151–4157.
  • Shimasaki N, Mori T, Torii C, . Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol. 2008;30:347–352.
  • Imanishi H, Okamura N, Yagi M, . Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet. 2007;52:166–171.
  • Ongaro A, De Mattei M, Della Porta MG, . Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. Haematologica. 2009;94:1391–1398.
  • Yang JJ, Cheng C, Yang W, . Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009;301:393–403.
  • Davies SM, Bhatia S, Ross JA, . Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002;100:67–71.
  • Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics. 2002;12:655–658.
  • Bolufer P, Collado M, Barragan E, . The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica. 2007;92:308–314.
  • Katoh M, Katoh M. Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico. Int J Mol Med. 2004;14:333–338.
  • Grise F, Bidaud A, Moreau V. Rho GTPases in hepatocellular carcinoma. Biochim Biophys Acta. 2009;1795:137–151.
  • Ohta Y, Hartwig JH, Stossel TP. FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling. Nat Cell Biol. 2006;8:803–814.
  • Shifrin Y, Arora PD, Ohta Y, . The role of FilGAP-filamin A interactions in mechanoprotection. Mol Biol Cell. 2009;20:1269–1279.
  • Kobayashi K, Terada C, Tsukamoto I. Methotrexate-induced apoptosis in hepatocytes after partial hepatectomy. Eur J Pharmacol. 2002;438:19–24.
  • Qu HQ, Grant SF, Bradfield JP, . Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies. J Med Genet. 2009;46:553–554.
  • Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol. 2006;24:771–800.
  • Lee SH, Yun S, Lee J, . RasGRP1 is required for human NK cell function. J Immunol. 2009;183:7931–7938.
  • Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology. 2004;127:1760–1774.
  • Saha B, Nandi D. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice. Hepatology. 2009;50:1547–1557.
  • Winter-Vann AM, Kamen BA, Bergo MO, . Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate. Proc Natl Acad Sci U S A. 2003;100:6529–6534.
  • Gao L, Macara IG, Joberty G. Multiple splice variants of Par3 and of a novel related gene, Par3L, produce proteins with different binding properties. Gene. 2002;294:99–107.
  • Kohjima M, Noda Y, Takeya R, . PAR3β, a novel homologue of the cell polarity protein PAR3, localizes to tight junctions. Biochem Biophys Res Commun. 2002;299:641–646.
  • Valdes AM, Loughlin J, Timms KM, . Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet. 2008;82:1231–1240.
  • Ikegawa S. New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol. 2007;19:429–434.
  • Morohashi Y, Hatano N, Ohya S, . Molecular cloning and characterization of CALP/KChIP4, a novel EF-hand protein interacting with presenilin 2 and voltage-gated potassium channel subunit Kv4. J Biol Chem. 2002;277:14965–14975.
  • Lee A, Beck L, Markovich D. The human renal sodium sulfate cotransporter (SLC13A1; hNaSi-1) cDNA and gene: organization, chromosomal localization, and functional characterization. Genomics. 2000;70:354–363.
  • Markovich D, Aronson PS. Specificity and regulation of renal sulfate transporters. Annu Rev Physiol. 2007;69:361–375.
  • Pruunsild P, Timmusk T. Structure, alternative splicing, and expression of the human and mouse KCNIP gene family. Genomics. 2005;86:581–593.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.